Home
About
Services
Partners
Client Portfolio
News
Contact
Pentagon announces F-35 jet prices for next three years
October 29, 2019
U.S. consumer confidence slips in October
October 29, 2019
0
Pfizer raises 2019 forecast as sales of cancer drug, heart medicine surge
Published by
Muller&Green
at
October 29, 2019
Categories
RSS
Tags
Pfizer Inc posted third-quarter profit well above analysts’ estimates on higher sales of cancer drug Ibrance and new heart medicine Vyndaqel, encouraging the largest U.S. drugmaker to lift its earnings forecast for the year.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more